Skip to main content
. 2024 May 31;13(8):396–405. doi: 10.1093/jpids/piae054

Table 2.

Estimated Slope and Difference in Slopes of Each Neonatal Biomarker by TDF Exposure Between 4 and 30 Days of Birth

Outcome Estimated Slope (95% CI) Estimated Difference in Slopes (95% CI)
TDF-Exposeda TDF-Unexposeda
Creatinine—mg/dL/day −0.006 (−0.010, −0.002) −0.008 (−0.015, −0.0002) 0.002 (−0.008, 0.012)
Phosphate—mg/dL/day −0.06 (−0.11, −0.01) −0.05, (−0.09, −0.02) −0.01 (−0.08, 0.06)
eGFR—mL/min/1.73 m2/day 0.96 (0.16, 1.76) 0.65 (−1.27, 2.56) 0.31 (−1.84, 2.46)
PTRPb—per day −0.58 (−0.74, −0.04) −0.084 (−0.44, 0.27) −0.50 (−0.88, −0.11)
25(OH)Db—ng/mL/day 0.048 (−0.35, 0.44) 0.02 (−0.52, 0.56) 0.03 (−0.68, 0.73)
PTHb—pg/mL/day −1.00, (−2.27, 0.27) 0.40 (−1.55, 2.35) −1.40 (−3.68, 0.89)
Urine NTxb—per day 12.82 (5.17, 20.47) 17.32 (13.44, 21.19) −4.49 (−12.73, 3.74)

aNumber of TDF-exposed and TDF-unexposed in each outcome model: creatinine N = 42, N = 18; phosphate N = 42, N = 18; eGFR N = 39, N = 18; PTRP N = 29, N = 9; 25(OH)D N = 30, N = 13; PTH N = 24, N = 11; NTx N = 30, N = 18.

b25(OH)D, 25-hydroxy vitamin D; PTH, parathyroid hormone; PTRP, percent tubular reabsorption of phosphate; urine NTx, urine cross-linked N-telopeptide of type 1 collagen normalized for creatinine.